An intermittent, controlled-rate, slow progressive degeneration model of Parkinson’s disease: antiparkinson effects of Sinemet and protective effects of methylphenidate
Authors:
- Sheila M. FlemingSFSheila M. Fleming
- Yvon DelvilleYDYvon Delville
- Timothy SchallertTSTimothy Schallert
- 1 January 2005
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 156 (2) , 201-213
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal PathwayExperimental Neurology, 2002
- Experience-Associated Structural Events, Subependymal Cellular Proliferative Activity, and Functional Recovery After Injury to the Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2000
- The Freezing of Time as a Presenting Symptom of Parkinson's DiseaseNew England Journal of Medicine, 1999
- Somatic Delivery of Catecholamines in the Striatum Attenuate Parkinsonian Symptoms and Widen the Therapeutic Window of Oral Sinemet in RatsExperimental Neurology, 1997
- Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to agingBrain Research, 1993
- Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatumBrain Research, 1991
- Aging‐dependent Emergence of Sensorimotor Dysfunction in Rats Recovered from Dopamine Depletion Sustained Early in LifeaAnnals of the New York Academy of Sciences, 1988
- I. MPTP neurotoxicity: An overview and characterization of phases of toxicityLife Sciences, 1985
- Supersensitivity after intraventricular 6-hydroxydopamine: Relation to dopamine depletionCellular and Molecular Life Sciences, 1980
- Time course of nigrostriatal degeneration in parkinson's diseaseJournal of Neural Transmission, 1976